Ass Prof ➡️ Med Affairs. Improving lives thru medicine 🧬. Human physiologist. ⚽️ coach. Sports lover. Living in paradise & enjoying every minute. 🇨🇭🇨🇦🇩🇪
10 years ago there may have been zero or maybe one ☢️ nuclear medicine abstracts at @ASCO. Theranostics is now🔥.
This year, ~90 presentations and a dedicated oral session.
For those attending @SNM_MI , we are doing a live cross with @HJacene . Mon June 1, 2026 4:45 PM room 515A
The progress and intensity of clinical research efforts with antibody-drug conjugates vs cancer is remarkable
A new @CellCellPress review
https://t.co/bkaJ2OOt63
PSA screening for prostate cancer reduces disease-specific deaths, new Cochran review shows. The benefit, though small, represents a significant change from a 2013 review https://t.co/RPL21WROw9 via @statnews
“We did the hardest thing in the history of American health care. We got the majority of American doctors to all voluntarily adopt a single technology platform.”
NBC News on how that happened, what U.S. physicians actually do with OpenEvidence, and how partnerships with NEJM, JAMA, NCCN, and Wiley make it possible.
Another huge medical achievement from our very own @UHN 🇨🇦🔥
A Toronto man lived with HIV for 27 years. Then he got leukemia and that diagnosis may have just cured him of both.
His doctors found a bone marrow donor carrying CCR5-Δ32, a rare mutation in ~1% of people of European descent. HIV hijacks immune cells through the CCR5 receptor. If you don't have it, the virus has no door.
The transplant replaced his entire immune system with one HIV can't infect.
He stopped antiretroviral therapy in July 2025. As of today, HIV is undetectable by the most sensitive assays available. No viral reservoir. No immune response to HIV. Nine months clean.
He would be the 11th person in history to possibly be cured of HIV.
HIV cure is possible. We just proved it again at @UHN
Proud of the team at @UHN and @UofT !
Source: https://t.co/zH1fIfVubV
$REGN wins FDA approval for its gene therapy to treat a very rare genetic form of hearing loss. The company is giving away the therapy for free.
OTOF-related hearing loss affects approx. 50 newborns per year, so really rare, but... are there any concerns from other gene therapy makers about a precedent being set whereby an otherwise expensive treatment is given away for free?